no doubt yuyu, that 3 million sell order at 2.7c has been well used to cap any shareprice appreciation.RCP could move heading into the close to get in ahead of the release of the scoping study/exploration results.
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution
